Fora Capital, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Fora Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$58.38 - $84.96 $376,317 - $547,652	-6,446 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$62.15 - $90.32 $400,618 - $582,202	6,446 New	6,446 $534 Million
Q1 2021 May 17, 2021	SELL	$61.35 - $90.47 $129,325 - $190,710	-2,108 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$43.82 - $85.37 $141,494 - $275,659	-3,229 Reduced 60.5%	2,108 $161,000
Q3 2020 Nov 13, 2020	SELL	$33.21 - $51.27 $264,584 - $408,468	-7,967 Reduced 59.88%	5,337 $230 Million

Q2 2020 Aug 14, 2020	SELL	$26.12 - $43.27 $30,926 - $51,231	-1,184 Reduced 8.17%	13,304 $575 Million
Q1 2020 May 15, 2020	BUY	$20.56 - $63.12 $19,285 - $59,206	938 Added 6.92%	14,488 $416,000
Q4 2019 Feb 14, 2020	BUY	$28.14 - $73.01 $381,297 - $989,285	13,550 New	13,550 $859,000

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.